ITRN:NASDAQIturan Location and Control Ltd. Analysis
Data as of 2026-07-06 - not real-time
$57.94
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
ITRN is trading well below its discounted cash‑flow estimate, suggesting a sizeable upside potential. The price sits above a clear technical support level and the RSI is approaching oversold territory, while the MACD has turned bearish but volume is on an upward trend, hinting at a possible reversal. Revenue growth remains robust, driven by a strong increase in subscription customers, and profitability metrics such as margins and return on equity are solid. The dividend yield is attractive, yet the payout ratio sits near full earnings, raising questions about long‑term sustainability.
Overall, the stock blends growth characteristics with a value‑oriented price, but investors should weigh the higher beta, elevated volatility, and geopolitical exposure in the primary operating regions. The combination of an undervalued valuation, recurring revenue base, and a supportive technical backdrop makes ITRN a compelling candidate for investors with a moderate risk tolerance.
Overall, the stock blends growth characteristics with a value‑oriented price, but investors should weigh the higher beta, elevated volatility, and geopolitical exposure in the primary operating regions. The combination of an undervalued valuation, recurring revenue base, and a supportive technical backdrop makes ITRN a compelling candidate for investors with a moderate risk tolerance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price above technical support
- increasing volume despite bearish MACD
- near‑oversold RSI
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- substantial subscriber growth
- valuation gap to DCF estimate
- strong operating margins
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- recurring telematics subscription model
- undervaluation relative to fundamentals
- exposure to expanding vehicle‑tracking market
Key Metrics & Analysis
Financial Health
Revenue Growth18.80%
Profit Margin16.03%
P/E Ratio19.0
ROE30.26%
ROA13.63%
Debt/Equity2.02
P/B Ratio5.5
Op. Cash Flow$91.4M
Free Cash Flow$70.4M
Industry P/E36.6
Technical Analysis
TrendBullish
RSI36.8
Support$56.79
Resistance$67.70
MA 20$62.95
MA 50$61.12
MA 200$48.00
MACDBearish
VolumeIncreasing
Fear & Greed Index93.63
Valuation
Fair Value$106.52
Target Price$73.50
Upside/Downside26.86%
GradeUndervalued
TypeGrowth
Dividend Yield3.50%
Risk Assessment
Beta1.21
Volatility36.08%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.